Calmodulinopathies: The Need for a Registry.

JACC Clin Electrophysiol

Istituto Auxologico Italiano IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milano, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy. Electronic address:

Published: September 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Calmodulinopathies are very rare genetic disorders associated with a high risk for sudden cardiac death. Disease-causing variants in 1 of the 3 identical CALM genes cause severe forms of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, or idiopathic ventricular fibrillation, and there are many unanswered questions concerning management and underlying mechanisms. What is currently known depends largely on the initial publications from the ICamR (International Calmodulinopathy Registry). However, progress is delayed because the accrual of patients in ICamR is slow. As we did long ago for long QT syndrome, this is a call for action, requesting doctors all over the world to enroll even their isolated cases in the Registry. This is the only way to obtain, for an adequate number of patients, the data necessary to define the spectrum of clinical manifestations and the genotype-phenotype correlation essential for an improved risk stratification and best therapeutic management. If you are willing to contribute, please contact us.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacep.2025.08.004DOI Listing

Publication Analysis

Top Keywords

long syndrome
8
calmodulinopathies registry
4
registry calmodulinopathies
4
calmodulinopathies rare
4
rare genetic
4
genetic disorders
4
disorders associated
4
associated high
4
high risk
4
risk sudden
4

Similar Publications

Ranolazine-Induced Type 1 Brugada Pattern.

JACC Case Rep

September 2025

Cardiovascular Diseases Section, Interdisciplinary Department of Medicine (DIM), University of Bari "Aldo Moro," Bari, Italy.

Background: Brugada syndrome (BrS) is a rare inherited arrhythmia disease carrying a variable risk of sudden cardiac death. Diagnosis requires the type 1 Brugada electrocardiographic pattern, which can either be spontaneous or induced by sodium channel-blocking drugs. Ranolazine is an antianginal drug acting on the late sodium current with emerging antiarrhythmic properties; no information is available on the safety of ranolazine use in patients with BrS.

View Article and Find Full Text PDF

Repurposed antihypertensive drugs for negative symptoms in schizophrenia: A systematic review and meta-analysis.

Psychiatry Clin Neurosci

September 2025

Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, Spain.

Schizophrenia is a complex psychiatric disorder characterized by positive, negative, and general psychopathological symptoms. While antipsychotic drugs are effective for positive symptoms, they provide limited benefit for negative symptoms, which are often persistent and strongly associated with functional disability. Additionally, up to 30% of patients exhibit resistance to current treatments, including clozapine.

View Article and Find Full Text PDF

Polytrauma patients are defined by the Berlin Consensus as those with severe injuries across multiple regions and require complex, adaptable treatment approaches to address both immediate and long-term needs of the patient, while considering the resource availability. This review evaluates early total care (ETC), which attempts early definitive fixation, against damage control orthopedics (DCO), which focuses on temporary stabilization to reduce physiological strain from surgery. While ETC promotes early mobilization, DCO reduces risks and subsequent complications associated with the "second hit" phenomenon in critically ill patients.

View Article and Find Full Text PDF

Background: Abnormal blood test results are common in both primary and specialist health care. The cause is often multifactorial, and investigations are often conducted across various specialties. We present a patient with incidental disturbances in the blood count with a serious causal relationship.

View Article and Find Full Text PDF

Objectives: To describe the clinical presentation of patients with gonadal neuroendocrine tumors and carcinoid heart disease (CaHD) and to evaluate long-term outcomes following valvular surgery.

Methods: Retrospective review of patients with primary gonadal neuroendocrine tumor who were surgically treated for CaHD at our institution between 1990 and 2021.

Results: Eight patients (median age, 70 years) were included in the study, 7 with ovarian tumors and 1 with testicular tumor.

View Article and Find Full Text PDF